Screener
Tempest Therapeutics TPST Q2 2026 earnings
Reported August 13, 2026 · After market close
EPS-$0.34Miss by $0.04
EPS estimate-$0.30
Next report
Nov 4, 2026 (in 2 months)EPS estimate-$0.35
Versus estimates
Diluted EPS
FAQ
- When did Tempest Therapeutics report Q2 2026 earnings?
- Tempest Therapeutics (TPST) reported Q2 2026 earnings on August 13, 2026 after market close.
- What were Tempest Therapeutics's Q2 2026 revenue and EPS?
- Tempest Therapeutics reported eps of $-0.34 for Q2 2026.
- Did Tempest Therapeutics beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.30 by $0.04.
- How did Tempest Therapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 83.6% from $-2.07.
- Where can I find Tempest Therapeutics's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-349334) and the 10-Q periodic report (0001193125-26-349381) directly on SEC EDGAR. The filing index links above go to sec.gov.
